South Sudan: Free medical care by Indian peacekeepers gives hope to over 300 displaced people
As security concerns continue in parts of Upper Nile state, the United Nations Mission in South Sudan (UNMISS) is making every effort to protect civilians and boost community confidence.
As an example—Blue Helmets from India hosted a two-day medical outreach at the UN Protection of Civilians site, adjacent to the Mission's base in Malakal where some 315 displaced people received free treatment.
Patients suffering from various ailments were diagnosed and provided with care options.
For Dr. Sandeep Ravi, a medical peacekeeper, such interventions lie at the heart of the UN Peacekeeping mission's mandate to help build lasting peace in this country.
'Accessible and inclusive healthcare is key for communities to thrive. Across Upper Nile state, conflict has disrupted not only people's lives and livelihoods but also reduced the number of available health facilities. So, we decided to come together and, for a limited time, bridge this gap as much as possible,' he explained.
'Bringing quality healthcare directly to communities goes beyond free consultations and treatment. It gives hope to people who are most vulnerable.'
Mary Joseph, a 20-year-old patient, can testify to Dr Ravi's opinion.
'I've had a problem with my leg for three months now but had no money to pay for treatment at the local clinics in town. Today, Indian doctors have examined me carefully and given me medications to treat the condition as well as manage my pain. I hope I can restart my small business soon,' she said with a smile.
Albino Amum, a community leader residing at the camp who helped peacekeepers mobilize this event, described the activity as timely and significant.
'Earlier, we were receiving healthcare from various international and nongovernmental organizations, but we understand that there is a reduction in funding, which has left a big vacuum. So, this medical drive by our friends at UNMISS came at a very opportune time. We hope they'll consider doing similar activities for us for five or six days in future. It makes a big difference for those who are financially constrained yet need urgent health checks,' stated Mr. Amum.
For his part, Dr. Ravi reveals that the biggest satisfaction was the response from community members.
'As medical professionals and peacekeepers, there is no greater reward than the genuine appreciation we have received from the displaced communities we treated. I believe this initiative is a testament to what collective effort and compassion can achieve in strengthening public health.'
Distributed by APO Group on behalf of United Nations Mission in South Sudan (UNMISS).
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Zawya
5 hours ago
- Zawya
South Sudan: Free medical care by Indian peacekeepers gives hope to over 300 displaced people
As security concerns continue in parts of Upper Nile state, the United Nations Mission in South Sudan (UNMISS) is making every effort to protect civilians and boost community confidence. As an example—Blue Helmets from India hosted a two-day medical outreach at the UN Protection of Civilians site, adjacent to the Mission's base in Malakal where some 315 displaced people received free treatment. Patients suffering from various ailments were diagnosed and provided with care options. For Dr. Sandeep Ravi, a medical peacekeeper, such interventions lie at the heart of the UN Peacekeeping mission's mandate to help build lasting peace in this country. 'Accessible and inclusive healthcare is key for communities to thrive. Across Upper Nile state, conflict has disrupted not only people's lives and livelihoods but also reduced the number of available health facilities. So, we decided to come together and, for a limited time, bridge this gap as much as possible,' he explained. 'Bringing quality healthcare directly to communities goes beyond free consultations and treatment. It gives hope to people who are most vulnerable.' Mary Joseph, a 20-year-old patient, can testify to Dr Ravi's opinion. 'I've had a problem with my leg for three months now but had no money to pay for treatment at the local clinics in town. Today, Indian doctors have examined me carefully and given me medications to treat the condition as well as manage my pain. I hope I can restart my small business soon,' she said with a smile. Albino Amum, a community leader residing at the camp who helped peacekeepers mobilize this event, described the activity as timely and significant. 'Earlier, we were receiving healthcare from various international and nongovernmental organizations, but we understand that there is a reduction in funding, which has left a big vacuum. So, this medical drive by our friends at UNMISS came at a very opportune time. We hope they'll consider doing similar activities for us for five or six days in future. It makes a big difference for those who are financially constrained yet need urgent health checks,' stated Mr. Amum. For his part, Dr. Ravi reveals that the biggest satisfaction was the response from community members. 'As medical professionals and peacekeepers, there is no greater reward than the genuine appreciation we have received from the displaced communities we treated. I believe this initiative is a testament to what collective effort and compassion can achieve in strengthening public health.' Distributed by APO Group on behalf of United Nations Mission in South Sudan (UNMISS).
Zawya
12 hours ago
- Zawya
DoH, Sanofi partner to accelerate development of new global vaccines in Abu Dhabi
The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in Abu Dhabi, has signed a Memorandum of Understanding (MoU) with Sanofi, a research and development-driven, AI-powered healthcare biopharma company at the BIO International Convention 2025, in Boston, USA. The collaboration will leverage the Emirate's health-tech ecosystem and advanced research infrastructure to drive the development of new global vaccines and strengthen regional capabilities in vaccine manufacturing. In the presence of Dr. Noura Khamis Al Ghaithi, Under-Secretary of the Department of Health – Abu Dhabi, and Laurie Gery, Global Head of Business Development, Vaccines at Sanofi, the agreement was signed during the BIO International Convention in Boston, USA, by Dr. Asma Al Mannaei, the Executive Director of the Health Life Sciences Sector at the DoH and Baptiste de Clarens, General Manager Greater Gulf, Vaccines at Sanofi. Dr. Asma Al Mannaei, Executive Director of the Health Life Sciences Sector at the DoH, said. 'DoH is partnering with Sanofi to expedite the development of new global vaccines. This initiative aims to shorten the timeline from early research to public availability by utilising advanced technologies, real-time data analysis, and conducting parallel clinical trial phases. By combining Sanofi's global scientific expertise with Abu Dhabi's state-of-the-art infrastructure, we set new benchmarks for resilience, innovation and international partnerships. Abu Dhabi offers a globally connected, purpose-driven environment for leading research, and together we will drive a transformative change that will safeguard the health and well-being of our community while contributing to global health security.' Both entities will work together to streamline regulatory processes, enhance manufacturing preparedness, and promote knowledge sharing between local and international experts. This partnership reflects Abu Dhabi's strategic goal to establish itself as a leading centre for bio- and pharmaceutical innovation and underscores the emirate's commitment to advancing proactive, technology-driven healthcare solutions. Baptiste de Clarens, General Manager Greater Gulf, Vaccines, Sanofi, said, 'The Memorandum of Understanding signed with the Department of Health – Abu Dhabi marks an encouraging step towards advancing global health security while reflecting our shared interest in addressing global health challenges through scientific partnership. This agreement allows us to examine how Sanofi's experience in vaccine development could complement Abu Dhabi's growing R&D ecosystem. Through this initial framework, we look forward to exploring opportunities for public-private collaboration in healthcare innovation.' In addition, both the Department and Sanofi will advance clinical research and development planning, optimise resource allocation and establish the foundational terms for funding and access. These efforts are designed to enhance healthcare resilience and sustainability across Abu Dhabi's healthcare sector and beyond, expanding access to quality care for patients locally and globally.
The National
a day ago
- The National
Abu Dhabi's dedicated cancer centre treats 25,000 patients in first two years
A dedicated Abu Dhabi cancer centre has delivered crucial treatment to more than 25,000 patients since opening to the public two years ago under a vision to transform health care in the Emirates. Health leaders at the Fatima bint Mubarak Centre, based at Cleveland Clinic Abu Dhabi, have told of their mission to "lead the future of oncology" from the UAE capital. Patients at the centre, which is modelled on Cleveland Clinic's Taussig Cancer Centre in the US, receive personalised care for in all forms of cancer from individual teams with expertise, comprises oncologists, surgeons, radiologists, radiation therapists, nurses and rehabilitation specialists. 'Gone are the days when a patient needs to go from place to place, everything they need is here,' said Dr Stephen Grobmyer, head of the Fatima bint Mubarak Cancer Centre, which opened in March 2023. Don't delay in seeking support But doctors say the public must also play their part to win the fight against cancer, by ensuring they do not delay in going for check-ups. 'We need people to understand that a delay in diagnosis is often a missed opportunity,' said Dr Fady Geara, chairman of radiation oncology. 'We are seeing patients who wait weeks or months before seeking help and, by the time they arrive, their window for a cure may already be closing.' The critical need for early intervention was highlighted in recent research, which indicated a 60 per cent rise in newly diagnosed cases between 2019 an 2023. The series paper, titled Cancer Control in the United Arab Emirates, co-written by leading UAE-based oncologists and global experts, called for an urgent and comprehensive national strategy to address rising cases, inequities in care and preventive services not being used enough. 'We're urging people to get screened, especially those with family histories or known risk factors,' Dr Geara said. 'The hardship of travelling abroad for care is no longer necessary. World-class treatment is available right here.' World-class care Dr Usman Ahmad, chairman of thoracic surgery, who leads the institute's robotic and minimally invasive surgery programme, agreed patients no longer having to travel abroad for treatment was a huge advantage. 'Robotic surgery allows us to operate through small keyhole incisions with exceptional precision and safety," he added. "The result is less pain, fewer complications and much faster recovery times.' The programme includes surgery for lung, oesophageal, stomach, prostate, kidney, bladder and gynaecological cancer. 'Our patients start walking the same day or the next, go home in a few days and recover fast enough to begin follow-up therapies such as chemotherapy or immunotherapy without delay,' said Dr Ahmad. Radiation oncology has also undergone major advancements under Dr Geara. 'We've brought in the most advanced technologies, including adaptive radiation therapy, brachytherapy and radio surgery,' he said. 'These methods reduce treatment sessions while improving cure rates and they're all now available right here in the UAE.' Brachytherapy, which involves using radiation directly on or near a tumour, is rarely found even in some major hospitals abroad. It is now carried out daily at the centre. Dr Geara said the institute had also begun work on a dedicated heavy ion therapy complex, a carbon-ion therapy considered among the most advanced in the world, capable of targeting tumours that cannot be treated through conventional means. Construction of the heavy ion centre is expected to take two to three years. Cleveland Clinic Abu Dhabi's cancer programme extends far beyond treatment. Under the leadership of Dr Fawad Khan, the longevity medicine section has introduced a pioneering preventive care programme for cancer survivors and those at high genetic risk of developing the disease. This includes comprehensive genetic screening, counselling and prevention strategies, from enhanced screening and medication to preventive surgery. The longevity medicine team comprises lifestyle physicians, physical therapists, genetic counsellors, naturopaths and psychologists. A major element of the programme is its use of precision genomics. 'We're conducting germ line, somatic and pharmacogenomic testing to guide treatment, prevent cancer and minimise side effects,' said Dr Khan. They collaborate closely with the Emirati Genome Programme and M42, allowing access to data crucial to bolstering care and mitigating health risks. One study now under way involves the use of polygenic risk scores to better identify breast cancer risks in Emirati women. 'This research has largely focused on western populations,' Dr Khan said. 'By focusing on Arab populations, we can greatly improve regional outcomes and design tailored prevention programmes.' Clinical trials are another growing sector. 'Trials are how new treatments come into the world,' said Dr Grobmyer. 'It's no longer enough to assume treatments tested abroad will work here. We need to prove they do with local data and regional representation.' A newly launched programme uses wearable BioButton sensors to track vital signs in real time once a patient leaves the hospital. Nurses can detect early signs of infection, dehydration, or other complications and intervene before symptoms worsen. 'The technology allows us to call patients before they call us,' said Dr Grobmyer. 'In many cases, we've been able to prevent hospital readmissions entirely.' He said the programme is already being used in chemotherapy patients and is expected to expand across surgical units. Long-term strategy The institute is also preparing the next generation of physicians. Next year, it will launch a four-year residency in oncology, accredited by the UAE board. Preference will be given to Emirati candidates, with the goal of building a sustainable domestic workforce in cancer care. 'Our long-term goal is not just to be takers of global excellence but contributors to it,' said Dr Grobmyer. 'Through clinical research, genomics, AI and training, we want to lead the future of oncology here in Abu Dhabi and around the world.'
